Tailored Breast Cancer Screening; Nov. 27, 2:00pm-3:30pm

This session considers risk assessment for breast cancer screening, protocols for screening beyond mammography and current controversies in breast cancer screening.

When: Sunday, Nov. 27, 2:00-3:30pm
Where: S406B

Speaker information:
Mark E. Robson, MD, clinical director clinical genetics service, Memorial Sloan-Kettering Cancer Center, New York City
D. David Dershaw, MD, director, breast imaging, Memorial Sloan-Kettering Cancer Center, New York City
Daniel B. Kopans, MD, director, breast imaging, Massachusetts General Hospital, Boston

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.